MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Holdings Cut by Handelsbanken Fonder AB
Handelsbanken Fonder AB reduced its position in shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) by 14.6% in the fourth quarter, HoldingsChannel.com reports. The firm owned 11,100 shares of the company’s stock after selling 1,900 shares during the period. Handelsbanken Fonder AB’s holdings in MoonLake Immunotherapeutics were worth $601,000 at the end of the most […]
